News
Boston Commercial Real Estate

LEED 4 PHARMA

Bristol-Myers Squibb, making its largest RE investment ever at the $750M, 300k SF Ft. Devens manufacturing complex, earned its first LEED designation last month. Its biopharma lab and office went Gold. The building will reduce greenhouse gas emissions (doesn't BMS make a drug for gas emissions, too?) and save on energy costs with its lighting, heating and cooling systems, water, and materials use. BMS also hopes that its just completed new factory at Devens will win a LEED green light sometime this summer, a rare feat for a biopharma manufacturing plant.

Continue reading this story with a free account

Log in or register
Related Topics: Myers Squibb
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Federal Government To Sell Nearly 31K SF In Five Points: The Denver Deal Sheet

Avison Young Had Assets Frozen By Bank Over Unpaid Taxes

Artificial Intelligence Companies Reshaping Dublin Office Demand As OpenAI Confirms HQ

Mars Factory Overhaul Stalls As Candymaker's Chicago Expansion Accelerates

Camden Property Trust Sells West Coast Portfolio, Clears $1.5B Target

Boston Property Owners Raise Alarms About Cost Of Electric-Building Push

Empire State Building Observation Deck Hemorrhaging Visitors, Value

Cortland, Pulte, INVH, Walker & Dunlop Execs Talk Changing Demographics, AI

America's War Machine Is Growing, Sparking A Defense Real Estate Boom

Clarion Under Contract To Sell 18-Story Seaport Office Tower

Boca Raton's New Leaders Throwing 'All Kinds Of Curveballs' At Developers

CBRE Posts 16% Revenue Growth In Q2 As Data Center Business Shines